A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Modified Xiaoyao San Ameliorates Depression-Like Behaviors and Neuronal Necroptosis in a Mouse Model of Chronic Unpredictable Mild Stress

82 views

⸱

DOI:

10.3791/72522

⸱

August 21st, 2026

In This Article

Summary

This protocol demonstrates the evaluation of Modified Xiaoyao San in a mouse model of chronic unpredictable mild stress-induced depression, including behavioral, histological, and molecular assessments of neuronal necroptosis.

Abstract

Neuronal loss and damage are important pathological features of depression, and necroptosis has been proposed as a potential mechanism of neuronal cell death. Analysis of Gene Expression Omnibus (GEO) datasets (GSE54565, GSE54566, and GSE54568) identified an association between depression and necroptosis, suggesting that inhibition of this pathway may represent a potential therapeutic strategy. Modified Xiaoyao San (MXYS), a modified formulation of the traditional Chinese medicine Xiaoyao San, was developed by incorporating heat-clearing, blood-cooling, cognitive-enhancing, and resuscitation-promoting herbs to improve therapeutic efficacy. However, its effects on neuronal necroptosis and the active constituents reaching brain tissue remain unclear. Ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS) was used to tentatively identify MXYS constituents detected in brain tissue. Therapeutic efficacy was evaluated in a chronic unpredictable mild stress (CUMS) mouse model of depression using behavioral assessments, histological examination, immunofluorescence, western blotting, and bioinformatic analyses. MXYS administration was associated with improved depression-like behaviors, attenuation of pathological brain injury, and reduced phosphorylation of receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like protein (MLKL). These findings suggest that MXYS exerts antidepressant-like effects that are associated with reduced neuronal necroptosis markers, providing experimental support for further investigation of MXYS as a potential therapeutic strategy for depression.

Introduction

Depression, a severe mental disorder within the spectrum of mood disorders, is characterized primarily by persistent low mood and is influenced by multiple factors1. Clinically, patients with depression commonly exhibit symptoms such as depressed mood, cognitive slowing, reduced verbal communication and physical activity, and, in severe cases, self-injurious behavior and suicidal ideation2. Owing to its high prevalence, recurrence, disability, and suicide rates, depression is a leading cause of disability worldwide and imposes substantial social and economic burdens3. According to the World Health....

Access restricted. Please log in or start a trial to view this content.

Protocol

The animal experiments were approved by the Animal Ethics Committee of Henan University of Chinese Medicine (approval no. DWLLGZR202200023). All procedures were conducted in accordance with institutional and national guidelines for animal welfare and complied with the ARRIVE guidelines. Male Sprague–Dawley (SD) rats were obtained from a licensed laboratory animal supplier. The animals were housed under controlled temperature and humidity with a 12 h light/dark cycle and provided standard chow and water ad libitum.

Identification of the Brain Tissue–Contained Components of MXYS
Preparation of Freeze-Dried MXY....

Access restricted. Please log in or start a trial to view this content.

Results

WGCNA Identifies a Depression-Associated Gene Module Enriched in the Necroptosis Pathway
The RRA package was used to integrate consistently upregulated and downregulated differentially expressed genes across the GSE54566, GSE54565, and GSE54568 datasets, resulting in the identification of 2,513 genes. A heat map of these genes is shown in Figure 1A. The three datasets were derived from distinct brain regions—the anterior cingulate cortex, amygdala, and dorsolateral prefr.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Abnormal neuronal death plays a crucial role in the pathogenesis of depression8. Necroptosis, a form of programmed cell death, has been extensively investigated, leading to significant advances in the development of inhibitors targeting this pathway39. Since the identification of the necroptosis inhibitor Nec-1 in 200540, considerable progress has been made in developing compounds that target key components of the necroptotic signaling pathway. Nec-1.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Conflicts of Interest:
The authors have nothing to disclose.

Acknowledgements

This work was supported by the Key Scientific Research Project of Henan Higher Education Institutions of China (No. 26A360008), the Scientific Research Project of Traditional Chinese Medicine of Henan Province (No. 2025ZY3152), the National Natural Science Foundation of China (No. 82274496), the Science and Technology Research Project of Henan Province (No. 232301420018), and the Zhang Zhongjing Inheritance and Innovation Project of the Science and Technology Department of the National Administration of Traditional Chinese Medicine (No. GZY-KJS-2022-044-1).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Acori Tatarinowii Rhizoma (Acorus tatarinowii Schott; Shi Changpu)Beijing Tongrentang Co., Ltd., Zhengzhou, China231001Herbal ingredient (12 g)
Adhesive tapeNot applicableNot applicableTail suspension test
Angelicae Sinensis Radix (Angelica sinensis (Oliv.) Diels; Dang Gui)Beijing Tongrentang Co., Ltd., Zhengzhou, ChinaG01230507-16Herbal ingredient (10 g)
Anti-ATF4 antibody (immunofluorescence)ServicebioGB111137Primary antibody
Anti-ATF4 antibody (western blot)MedChemExpressHY-P80486Primary antibody
Anti-BDNF antibodyMedChemExpressHY-P80567Primary antibody for western blot
Anti-CREB antibodyBeyotimeAF1018Primary antibody for western blot and immunofluorescence
Anti-GAPDH antibodyAbcamab181602Loading control
Anti-MLKL antibodyProteintech66675-1-IgPrimary antibody for western blot and immunofluorescence
Anti-NeuN antibodyServicebioGB11138Primary antibody for immunofluorescence
Anti-phospho-CREB antibodyBeyotimeAF5785Primary antibody
Anti-phospho-MLKL antibodyBiossbsm-54104RPrimary antibody
Anti-phospho-RIPK1 antibodyBiolynxBX60008Primary antibody
Anti-phospho-RIPK3 antibodyAbcamab195117Primary antibody
Anti-RIPK1 antibodyCell Signaling Technology3493SPrimary antibody
Anti-RIPK3 antibodyProteintech17563-1-APPrimary antibody
Atractylodes macrocephala (Atractylodes macrocephala Koidz.; Bai Zhu)Beijing Tongrentang Co., Ltd., Zhengzhou, China230801Herbal ingredient (10 g)
Automated behavioral tracking softwarePanlab (Harvard Apparatus)N/ASMART 3.0 video tracking software for open field and tail suspension tests
BCA Protein Assay KitCWBIOCW0014SProtein quantification
Behavioral recording systemPanlab (Harvard Apparatus)SMART V3.0Open field and tail suspension tests
Bio-Rad chemiluminescence imaging systemBio-Rad12003154ChemiDoc MP Imaging System for chemiluminescence western blot detection
CellTiter-Lumi II Luminescent Cell Viability Assay KitBeyotimeC0056XLCell viability assay
Confocal microscopeNikon Eclipse C1N/AImmunofluorescence imaging
DAPIServicebioG1012Nuclear stain
Environmental dewaxing solutionServicebioG1128Paraffin deparaffinization
Fetal bovine serum (FBS)BIC04001-500Cell culture supplement
Gardeniae Fructus (Gardenia jasminoides J. Ellis; Zhi Zi)Beijing Tongrentang Co., Ltd., Zhengzhou, China22102109Herbal ingredient (12 g)
Glycyrrhizae Radix (Glycyrrhiza uralensis Fisch.; Gan Cao)Beijing Tongrentang Co., Ltd., Zhengzhou, China230301Herbal ingredient (3 g)
CY3-conjugated goat anti-mouse IgGServicebioGB21301Fluorescent secondary antibody for mouse anti-ATF4 (IF, CY3, 1:300)
Alexa Fluor 488-conjugated goat anti-mouse IgGServicebioGB25301Fluorescent secondary antibody for mouse anti-MLKL (IF, Alexa Fluor 488, 1:400)
CY3-conjugated goat anti-rabbit IgGServicebioGB21303Fluorescent secondary antibody for rabbit anti-NeuN (IF, CY3, 1:300)
Alexa Fluor 488-conjugated goat anti-rabbit IgGServicebioGB25303Fluorescent secondary antibody for rabbit anti-CREB (IF, Alexa Fluor 488, 1:400)
HRP goat anti-rabbit IgGAbsinabs20040Secondary antibody for western blot
HRP-conjugated mouse anti-rabbit IgG light chainABclonalAS061Secondary antibody for western blot
Human TNF-αNovoproteinC008Necroptosis inducer
HT-22 cellsProcellCL-0697RRID: CVCL_0321
HyClone growth mediumCytiva (HyClone)SH30022.01Cell culture medium
ImageJNIHFree softwareBand quantification
Inverted microscopeNikonEclipse Ti-SRCell morphology
Liquid nitrogenHenan Jilai New Energy Technology Co., Ltd.N/ATissue preservation
Molecular Devices microplate readerMolecular DevicesSpectraMax M5Luminescence measurement
Moutan Cortex (Paeonia suffruticosa Andr.; Mu Danpi)Beijing Tongrentang Co., Ltd., Zhengzhou, China22121714Herbal ingredient (12 g)
Necrostatin-1 (Nec-1)SelleckS8037RIPK1 inhibitor
ParaformaldehydeServicebioG1101-500MLTissue fixation
Paroxetine hydrochloride hemihydrateAladdinP129711Positive control
PBSServicebioG4202-500MLWashing buffer
Peppermint (Mentha haplocalyx Briq.; Bo He)Beijing Tongrentang Co., Ltd., Zhengzhou, China230101Herbal ingredient (6 g)
Penicillin–streptomycinGibco15140-122Cell culture antibiotic
Polygalae Radix (Polygala tenuifolia Willd.; Yuan Zhi)Beijing Tongrentang Co., Ltd., Zhengzhou, China20221101Herbal ingredient (12 g)
Polyvinylidene fluoride (PVDF) membraneMerck MilliporeISEQ00010Western blot
Poria (Wolfiporia cocos; Fu Ling)Beijing Tongrentang Co., Ltd., Zhengzhou, ChinaD23070601Herbal ingredient (15 g)
Radioimmunoprecipitation assay (RIPA) lysis bufferCWBIO (Jiangsu Cowin Biotech Co., Ltd.)CW2333SProtein extraction
Radix Bupleuri (Bupleurum chinense DC.; Chai Hu)Beijing Tongrentang Co., Ltd., Zhengzhou, China230801Herbal ingredient (12 g)
SDS-PAGE reagentsSolarbio; Servicebio; Shanghai Yuanye Bio-Technology Co., Ltd.Not applicableAcrylamide, bis-acrylamide, Tris, SDS, APS, and TEMED prepared in-house
Sodium pentobarbitalSinopharm Chemical Reagent Co., Ltd.69020181Anesthetic
Ultra-high-performance liquid chromatography systemThermo Fisher ScientificVanquish UHPLC SystemLC-MS analysis
UHPLC HSS-T3 column (100 × 2.1 mm, 1.8 μm)Waters186003539Chromatographic separation
z-VAD-fmkTargetMolT6013Pan-caspase inhibitor

References

  1. Zhang Y, et al. Natural volatile oils derived from herbal medicines: A promising therapy way for treating depressive disorder. Pharmacol Res. 2021;164:105376.
  2. O’Connor EA, et al. Depression and suicide risk screening: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;329(23):2068-85.
  3. World Health Organization. The global burden of disease: 2004 update. World Health Organization; Geneva; 2008.
  4. Pedrosa-Naudín MA, et al. Non-adherence to antidepressant treatment and related factors in a region of Spain: A population-based registry study. Pharmaceutics. 2022;14(12):2696.
  5. Huang Y, et al.....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Depression Mouse ModelChronic Unpredictable StressBehavioral AssessmentWestern BlottingImmunofluorescence AnalysisBrain Tissue InjuryRIPK3 PhosphorylationUHPLC-HRMS